Meilan Liu

2.1k total citations
46 papers, 1.6k citations indexed

About

Meilan Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meilan Liu has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Meilan Liu's work include PARP inhibition in cancer therapy (7 papers), Cell death mechanisms and regulation (6 papers) and Cancer-related Molecular Pathways (6 papers). Meilan Liu is often cited by papers focused on PARP inhibition in cancer therapy (7 papers), Cell death mechanisms and regulation (6 papers) and Cancer-related Molecular Pathways (6 papers). Meilan Liu collaborates with scholars based in United States, China and Canada. Meilan Liu's co-authors include Felix Y. Feng, Lori J. Pierce, Corey Speers, Theodore S. Lawrence, Liang Xu, Zaneta Nikolovska‐Coleska, Wenhua Tang, Yao Dai, Harry Bartelink and Arul M. Chinnaiyan and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Meilan Liu

41 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Meilan Liu 995 575 427 292 195 46 1.6k
Toshihiko Nishidate 1.6k 1.6× 623 1.1× 285 0.7× 258 0.9× 241 1.2× 49 2.3k
Sebastian Oeck 907 0.9× 379 0.7× 322 0.8× 248 0.8× 129 0.7× 30 1.3k
Hwang‐Phill Kim 808 0.8× 660 1.1× 260 0.6× 304 1.0× 101 0.5× 42 1.5k
Naoise C. Synnott 793 0.8× 706 1.2× 370 0.9× 235 0.8× 101 0.5× 26 1.4k
Milind Suraokar 1.4k 1.4× 524 0.9× 717 1.7× 441 1.5× 93 0.5× 29 2.0k
Sergej Skvortsov 1.2k 1.2× 780 1.4× 605 1.4× 332 1.1× 197 1.0× 48 2.1k
Radosław Januchowski 1.1k 1.1× 736 1.3× 476 1.1× 125 0.4× 224 1.1× 53 1.8k
Qingxia Fan 1.4k 1.4× 717 1.2× 996 2.3× 486 1.7× 157 0.8× 111 2.3k
Francesca Bruzzese 1.2k 1.2× 593 1.0× 308 0.7× 293 1.0× 116 0.6× 55 1.7k
Pengfei Shi 956 1.0× 656 1.1× 460 1.1× 166 0.6× 169 0.9× 15 1.5k

Countries citing papers authored by Meilan Liu

Since Specialization
Citations

This map shows the geographic impact of Meilan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilan Liu more than expected).

Fields of papers citing papers by Meilan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meilan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilan Liu. The network helps show where Meilan Liu may publish in the future.

Co-authorship network of co-authors of Meilan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Meilan Liu. A scholar is included among the top collaborators of Meilan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meilan Liu. Meilan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rana, Priyanka S., et al.. (2025). MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer. PubMed. 26(5). 2245–2245. 1 indexed citations
2.
Liu, Ye, Ziwei Chen, Chang Li, et al.. (2025). Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis. BMC Gastroenterology. 25(1). 16–16. 7 indexed citations
3.
Chen, Xiong, et al.. (2024). Mediating Effect of Coping Style Between Risk Perception of Complications and Self-Management in Patients with Type 2 Diabetes Mellitus. Diabetes Metabolic Syndrome and Obesity. Volume 17. 4367–4376.
4.
5.
Chandler, Benjamin C., Anna R. Michmerhuizen, Kari Wilder-Romans, et al.. (2022). Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression. Cancer Research Communications. 2(7). 679–693. 7 indexed citations
6.
Michmerhuizen, Anna R., Rachel Schwartz, Kari Wilder-Romans, et al.. (2022). Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. npj Breast Cancer. 8(1). 31–31. 14 indexed citations
7.
Michmerhuizen, Anna R., Kari Wilder-Romans, Benjamin C. Chandler, et al.. (2021). RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes. JCI Insight. 7(3). 21 indexed citations
8.
Chandler, Benjamin C., Anna R. Michmerhuizen, Kari Wilder-Romans, et al.. (2020). Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers. Clinical Cancer Research. 26(24). 6568–6580. 35 indexed citations
9.
Michmerhuizen, Anna R., Benjamin C. Chandler, Kari Wilder-Romans, et al.. (2019). PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation. Molecular Cancer Therapeutics. 18(11). 2063–2073. 41 indexed citations
10.
Liu, Meilan, et al.. (2019). ENERGY MEASURES ACROSS HOCKEY HELMET IMPACT LOCATIONS. ISBS Proceedings Archive. 37(1). 443. 1 indexed citations
11.
Zhang, Yuanyuan, Yuhui Zhang, Chunmei Li, et al.. (2019). NOD1 modulates decidual stromal cell function to maintain pregnancy in the early trimester. Cell Biochemistry and Function. 37(7). 464–473. 13 indexed citations
12.
Liu, Meilan, et al.. (2019). The expression profile of circRNA and its potential regulatory targets in the placentas of severe pre-eclampsia. Taiwanese Journal of Obstetrics and Gynecology. 58(6). 769–777. 23 indexed citations
13.
Speers, Corey, Shuang G. Zhao, Vishal Kothari, et al.. (2016). Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer. Clinical Cancer Research. 22(23). 5864–5875. 82 indexed citations
14.
Speers, Corey, Shuang Zhao, Meilan Liu, et al.. (2015). Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer. Clinical Cancer Research. 21(16). 3667–3677. 114 indexed citations
15.
Malik, Rohit, Lalit R. Patel, John R. Prensner, et al.. (2014). The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer. Molecular Cancer Research. 12(8). 1081–1087. 112 indexed citations
16.
Abulwerdi, Fardokht A., Chenzhong Liao, Meilan Liu, et al.. (2013). A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo. Molecular Cancer Therapeutics. 13(3). 565–575. 158 indexed citations
17.
Brenner, J. Chad, Felix Y. Feng, Sumin Han, et al.. (2012). PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma. Cancer Research. 72(7). 1608–1613. 206 indexed citations
18.
Lü, Jianfeng, Donna McEachern, Haiying Sun, et al.. (2011). Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment. Molecular Cancer Therapeutics. 10(5). 902–914. 51 indexed citations
19.
Meng, Yang, Wenhua Tang, Yao Dai, et al.. (2008). Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Molecular Cancer Therapeutics. 7(7). 2192–2202. 167 indexed citations
20.
Shangary, Sanjeev, Ke Ding, Su Qiu, et al.. (2008). Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer. Molecular Cancer Therapeutics. 7(6). 1533–1542. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshihiko Nishidate Breakdown of academic impact, for papers by Sebastian Oeck Breakdown of academic impact, for papers by Hwang‐Phill Kim Breakdown of academic impact, for papers by Naoise C. Synnott Breakdown of academic impact, for papers by Milind Suraokar Breakdown of academic impact, for papers by Sergej Skvortsov Breakdown of academic impact, for papers by Radosław Januchowski Breakdown of academic impact, for papers by Qingxia Fan Breakdown of academic impact, for papers by Francesca Bruzzese Breakdown of academic impact, for papers by Pengfei Shi
Rankless by CCL
2026